SCHEMBL1369259

SCHEMBL1369259

COc1ccc(/C=C\C(=O)NC(=O)c2cc3c(OC)cccc3oc2=O)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 5/20 0.61
KMT2A Q03164 3/20 0.53
RAB9A P51151 3/20 0.53
KDM4E B2RXH2 2/20 0.53
MEN1 O00255 2/20 0.53
MAPT P10636 2/20 0.53
PLIN1 O60240 1/20 0.53
ALDH1A1 P00352 1/20 0.53
LMNA P02545 1/20 0.53
PLIN5 Q00G26 1/20 0.53
ABHD5 Q8WTS1 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
MAOA P21397 2/20 0.50
GAA P10253 2/20 0.48
MGAM O43451 1/20 0.48
SI P14410 1/20 0.48
MGAM2 Q2M2H8 1/20 0.48
HDAC1 Q13547 2/20 0.47
CNR1 P21554 1/20 0.46
GPR55 Q9Y2T6 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1368512 1.00 MAOB (0.61) MAOBKMT2ARAB9AKDM4EMEN1
SCHEMBL1368510 1.00 MAOB (0.61) MAOBKMT2ARAB9AKDM4EMEN1
SCHEMBL1368197 0.89 MAOB (0.63) MAOBKMT2ARAB9AKDM4EMEN1
SCHEMBL1368199 0.89 MAOB (0.63) MAOBKMT2ARAB9AKDM4EMEN1
SCHEMBL1368516 0.89 MAOB (0.63) MAOBKMT2ARAB9AKDM4EMEN1
SCHEMBL1367143 0.86 MAOB (0.61) MAOBKMT2ARAB9AKDM4EMEN1
SCHEMBL1368562 0.86 MAOB (0.61) MAOBKMT2ARAB9AKDM4EMEN1
SCHEMBL1367145 0.86 MAOB (0.61) MAOBKMT2ARAB9AKDM4EMEN1
SCHEMBL4346162 0.81 ALDH1A1 (0.64) MAOBKMT2ARAB9AKDM4EMAPT
SCHEMBL4347045 0.81 ALDH1A1 (0.64) MAOBKMT2ARAB9AKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090275650-A1 3-Acyl coumarins, thiochromones and quinolones and therapeutic uses thereof TEMPLE UNIVERSITY- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-11-05 US claimed
US-8067461-B2 3-acyl coumarins, thiochromones and quinolones and therapeutic uses thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2011-11-29 US disclosed
US-20090275650-A1 3-Acyl coumarins, thiochromones and quinolones and therapeutic uses thereof TEMPLE UNIVERSITY- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275650-A1 3-Acyl coumarins, thiochromones and quinolones and therapeutic uses thereof NQO2, NQO1, HCCS MAOB 2929/4885KMT2A 1726/4885RAB9A 1991/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.